Tumours in the treatment group that obtained Tepro-mAB-P/EWS-FLI1-siRNA/P nanoparticles showed a significant and almost complete growth inhibition when compared to both control groups (Fig. 8D, E). The gene discussed is EWSR1; the disease is neoplasm.